Investigation of multi-drug resistance 1 (MDR1) and cytochrome P4502C8 (CYP2C8) pharmacogenetics on outcome from treatment of advanced breast cancer using paclitaxel in a UK national trial of a weekly versus 3-weekly schedule.

  1. Lookup NU author(s)
  2. Dr Jo Lee
  3. Julieann Sludden
  4. Professor Alan Boddy
  5. Dr Mark Verrill
Author(s)Lee, J. S., Sludden, J., Ferrigan, L. M., Boddy, A. V., Verrill, M. W., Cameron, D.
Publication type Conference Proceedings (inc. Abstract)
Conference Name29th Annual San Antonio Breast Symposium
Conference LocationSan Antonio, Texas, USA
Year of Conference2006
Legacy Date14/17-12-2006
Number of Volumes1
PagesS252 no. 5118
Sponsor(s)San Antonio Cancer Institute, Baylor College of Medicine, Cancer Therapy and Research Center, The University of Texas
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherBreast Cancer Research and Treatment, Springer Netherlands
Actions    Link to this publication
Library holdingsSearch Newcastle University Library for this item